ArticlemAbs2026
NAStructuralDB : structural database to facilitate computational studies of molecular modeling and recognition of proteins with special focus on antibody-antigen interactions.
Article in mAbs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- ASD: antigen-specific antibody database.mAbs · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Studying the interactions between antibodies and antigens is fundamental to the development of novel therapeutic biologics. Predictions of such interactions start with data collection. Though there exist reliable resources to identify antibody structures in the Protein Data Bank (PDB), such data still requires substantial processing to be usable in predictive tasks. Redundancy in sequences needs to be removed to avoid data leakages between train, test, and validation sets. Descriptors such as surface accessibility, secondary structure, and antibody region information need to be additionally annotated. Information on inter- and intra-molecular contacts, which is crucial to studying paratope/epitope information, needs to be collected. The specialized immunoglobulin format of Nanobodies® requires a separate dataset mirroring that of antibodies, given that their structure contains only a single VHH chain. Because antibody-antigen structures account for a small amount of all protein-protein contacts, having a molecular contact reference from other proteins is also desired. To address these issues, we introduce NAStructuralDB (https://naturalantibody.com/na-structural/), a dataset of processed structures of antibodies, Nanobodies®, proteins, and their complexes with molecular contact information and associated annotations. We use the opportunity of having collected the contact data to provide a reference of binding propensities of different residues across distinct contact types.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.